肾细胞癌的遗传易感性:咨询、检测、筛查与管理的意义
本文综述肾细胞癌遗传易感性的评估与管理。遗传因素可能参与部分肾细胞癌的发生,早发、多灶或双侧肿瘤、家族史等提示遗传可能。评估始于遗传咨询和家系分析,检测采用二代测序同时评估多基因,结果对患者及家属有重要意义,并指导肾脏及高危器官筛查,遗传性肾癌的管理可能与散发性不同。
要点
- 早发、多灶或双侧肾癌、家族史等提示遗传性肾细胞癌可能。
- 遗传咨询和家系分析是评估第一步,决定是否进行基因检测。
- 二代测序可同时评估多个基因,结果指导筛查和管理。
核心结论
- 遗传因素可能参与部分肾细胞癌的发生,遗传咨询、基因检测和筛查对患者及家属有重要意义。
研究设计与样本
- 本文为综述,未报告系统检索范围。
主要发现
- 早发、多灶或双侧肿瘤、家族史、个人或家族其他良恶性肿瘤史等风险因素可提示遗传可能。
- 检测方法已转变为二代测序,可同时评估多个基因。
- 检测结果对患者及其家庭成员有重要意义,并启动肾脏及高危器官筛查。
- 遗传性肾癌的管理可能与散发性肾细胞癌不同。
临床怎么用
- 对提示遗传可能的肾细胞癌患者,应先行遗传咨询和家系分析,再决定是否检测。
- 基因检测结果可用于指导肾脏及高危器官的筛查方案。
- 遗传性肾癌的管理可能需要 multidisciplinary 团队,必要时可加速遗传评估以辅助治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In many individuals with renal cell carcinoma (RCC), a hereditary cause may have contributed to cancer development. Various risk factors can be suggestive of a genetic contribution, including early disease onset, multifocal or bilateral tumors, family history of RCC, and personal/family history of other benign or malignant tumors. Genetic counseling and understanding of the entire family tree are the first steps in evaluation and will determine if the patient should proceed with testing. Methods of testing have changed to next-generation sequencing, which allows multiple genes to be evaluated together. The results of testing have significant implications for the individual and his or her family members. Screening of the kidney and at-risk organs ensues, with most algorithms focused on early diagnosis and intervention to limit morbidity and mortality of disease manifestations. A comprehensive clinical program that can offer multidisciplinary care is useful for several complex cancer syndromes. Management of localized and advanced hereditary kidney cancers may differ from the sporadic forms of RCC. Knowledge of the genetics can have significant management implications and if necessary genetic evaluation can be expedited to allow treatment decisions.
引用
- Shuch B, Zhang J. Genetic Predisposition to Renal Cell Carcinoma: Implications for Counseling, Testing, Screening, and Management. J Clin Oncol. 2018. PMID: 30372385. doi:10.1200/JCO.2018.79.2523
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。